Kintara Therapeutics Top Insiders
Kintara Therapeutics employs about 2 people. The company is managed by 11 executives with a total tenure of roughly 95 years, averaging almost 8.0 years of service per executive, having 0.18 employees per reported executive. Assessment of Kintara Therapeutics' management performance can provide insight into the firm performance.
| Jeffrey Bacha CEO President CEO, Director |
Kintara |
Kintara Therapeutics Workforce Comparison
Kintara Therapeutics is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 48,389. Kintara Therapeutics adds roughly 2.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Kintara Therapeutics Notable Stakeholders
A Kintara Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kintara Therapeutics often face trade-offs trying to please all of them. Kintara Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kintara Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeffrey Bacha | President CEO, Director | Profile | |
| Scott Praill | CFO and Principal Accounting Officer | Profile | |
| John Bell | Independent Director | Profile | |
| William Garner | Director | Profile | |
| Erich Mohr | Independent Director | Profile | |
| Saiid Zarrabian | Director | Profile | |
| Robert Toth | Director | Profile | |
| Dennis Brown | Chief Scientific Officer, Director | Profile | |
| Lynda Cranston | Independent Director | Profile | |
| Robert Hoffman | Independent Director | Profile | |
| Napoleone Ferrara | Director | Profile |
Kintara Therapeutics Workforce Analysis
Traditionally, organizations such as Kintara Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kintara Therapeutics within its industry.Kintara Therapeutics Manpower Efficiency
Return on Kintara Therapeutics Manpower
| Net Loss Per Employee | 4M | |
| Net Loss Per Executive | 718.2K | |
| Working Capital Per Employee | 2.3M | |
| Working Capital Per Executive | 412.1K |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Kintara Stock
If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |